comparemela.com
Home
Live Updates
Chinas NMPA approves Zai Labs XACDURO NDA for pneumonia : comparemela.com
China's NMPA approves Zai Lab's XACDURO NDA for pneumonia
The NMPA's decision was based on the positive outcomes of the Phase III ATTACK trial.
Related Keywords
New Zealand
,
Australia
,
Vietnam
,
Republic Of
,
China
,
Japan
,
Chinese
,
Harald Reinhart
,
Drug Administration
,
Zai Lab
,
China National Medical Products Administration
,
Innoviva Specialty Therapeutics
,
National Medical Products Administration
,
Entasis Therapeutics
,
Greater China
,
Pharmaceutical Technology
,
comparemela.com © 2020. All Rights Reserved.